ATE113837T1 - Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung. - Google Patents

Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung.

Info

Publication number
ATE113837T1
ATE113837T1 AT86902214T AT86902214T ATE113837T1 AT E113837 T1 ATE113837 T1 AT E113837T1 AT 86902214 T AT86902214 T AT 86902214T AT 86902214 T AT86902214 T AT 86902214T AT E113837 T1 ATE113837 T1 AT E113837T1
Authority
AT
Austria
Prior art keywords
depression
calm
agents
compositions
combat pain
Prior art date
Application number
AT86902214T
Other languages
English (en)
Inventor
Martin G Crosby
Original Assignee
Serotonin Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serotonin Ind filed Critical Serotonin Ind
Application granted granted Critical
Publication of ATE113837T1 publication Critical patent/ATE113837T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Manufacture Of Tobacco Products (AREA)
AT86902214T 1985-03-26 1986-03-21 Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung. ATE113837T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71610085A 1985-03-26 1985-03-26
US06/755,367 US4596807A (en) 1985-03-26 1985-07-16 Method and compositions for controlling pain, depression and sedation

Publications (1)

Publication Number Publication Date
ATE113837T1 true ATE113837T1 (de) 1994-11-15

Family

ID=27109475

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86902214T ATE113837T1 (de) 1985-03-26 1986-03-21 Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung.

Country Status (7)

Country Link
US (1) US4596807A (de)
EP (1) EP0222782B1 (de)
AT (1) ATE113837T1 (de)
AU (1) AU586859B2 (de)
DE (1) DE3650138D1 (de)
GR (1) GR860762B (de)
WO (1) WO1986005684A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
US4833154A (en) * 1987-12-14 1989-05-23 Jean Louis Louis J Natural sleeping pill to prevent and alleviate insomnia
JPH0395115A (ja) * 1989-06-15 1991-04-19 Taisho Pharmaceut Co Ltd 鎭咳剤
US5104899A (en) * 1990-08-13 1992-04-14 Sepracor, Inc. Methods and compositions for treating depression using optically pure fluoxetine
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5512593A (en) * 1993-03-02 1996-04-30 John S. Nagle Composition and method of treating depression using natoxone or naltrexone in combination with a serotonin reuptake inhibitor
WO1996022085A1 (en) * 1995-01-17 1996-07-25 Pfizer Inc. The use of sertraline to treat cancer patients
US6017946A (en) * 1997-10-08 2000-01-25 Posner; Robert Serotonin containing formulation for oral administration and method of use
US5939076A (en) * 1997-11-12 1999-08-17 Allocca Techical, Inc. Composition and method for treating or alleviating migraine headaches
US6176242B1 (en) 1999-04-30 2001-01-23 Medtronic Inc Method of treating manic depression by brain infusion
ES2246485T3 (es) * 1999-07-01 2006-02-16 PHARMACIA & UPJOHN COMPANY LLC (s,s)-reboxetina para tratar la incontinencia.
US6403657B1 (en) * 1999-10-04 2002-06-11 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity
US6871098B2 (en) * 2000-10-30 2005-03-22 Medtronic, Inc. Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
US7034059B2 (en) * 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
AUPR626201A0 (en) * 2001-07-10 2001-08-02 Bioscreen Pty Ltd A composition for use in prophylaxis and/or treatment
WO2003011289A1 (en) * 2001-07-31 2003-02-13 Pharmacia + Upjohn Company Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines
EP1411912A1 (de) * 2001-07-31 2004-04-28 PHARMACIA & UPJOHN COMPANY Behandlung von chronischen schmerzen mit 3-aryloxy-3-phenylpropanaminen
US20030091553A1 (en) * 2001-10-19 2003-05-15 Gehlsen Kurt R. Use of histamine to treat liver disease
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
AU2003222045A1 (en) * 2002-03-21 2003-10-08 Martin C. Hinz Serotonin and catecholamine system segment optimization techonology
US20060110325A1 (en) * 2003-02-21 2006-05-25 Hinz Martin C Serotonin and catecholamine segment optimization technology
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
CA2497824A1 (en) * 2002-09-05 2004-03-18 Pantarhei Bioscience B.V. Use of a sri and vitamin b6 for the treatment of neurological and mental disorders
US20070117844A1 (en) * 2005-11-18 2007-05-24 Morillo Connie S 5-HTP combination therapy
CN101868233A (zh) * 2007-09-24 2010-10-20 H.隆德贝克有限公司 与血清素双重作用化合物有关的组合疗法
US9468611B2 (en) * 2012-09-27 2016-10-18 Relmada Therapeutics, Inc. d-Methadone for the treatment of psychiatric symptoms
RU2706700C1 (ru) * 2019-09-24 2019-11-20 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione

Also Published As

Publication number Publication date
WO1986005684A1 (en) 1986-10-09
EP0222782B1 (de) 1994-11-09
EP0222782A4 (de) 1987-08-12
AU5621586A (en) 1986-10-23
US4596807A (en) 1986-06-24
EP0222782A1 (de) 1987-05-27
AU586859B2 (en) 1989-07-27
GR860762B (en) 1986-07-21
DE3650138D1 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
ATE113837T1 (de) Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung.
ATE398464T1 (de) Synergie zwischen apo-2 ligand und antikörper gegen her-2
ATE437867T1 (de) Substituierte indole zur modulierung von nfkb- aktivität
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
DE60028971D1 (de) Apo-2l rezeptor-agonist und cpt-11 synergie-effekt
ATE406882T1 (de) Zusammensetzungen zur normalisierung des zirkadianen rythmus
PT1014961E (pt) Tratamento da cefaleia de enxaqueca utilizando metoclopramida e um nsaid
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
ATE447952T1 (de) Synergistische kombination von pumafentrine und salmeterol
BR9714415A (pt) Heterociclos contendo nitrogênio substituìdo como inibidores de proteìnas quinase p38
PT1347971E (pt) Inibidores tiazolilicos de tirosina-cinases da familia tec
BR9811482A (pt) Derivados de 1-(n-fenilaminoalquil)-piperazina substituìda na posição 2 do anel fenìlico
ES2177112T3 (es) Agentes angiostaticos y composiciones para tratar el glaucoma glc1a.
BR0315777A (pt) Uso de derivados de piperazina como antagonistas ccr1
RU2000129121A (ru) Комбинации рилузола с l-дофа для лечения болезни паркинсона
DE60124387D1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
ES2165586T3 (es) Derivados de isatina como inhibidores de acetilcolinesterasa y analgesicos.
BR0208695A (pt) Composições e métodos para a prevenção e tratamento de c ncer humano da próstata
DE69330150D1 (de) Pharmazeutische Zusammensetzungen zur transdermalen Verabreichung von Melatonin und/oder seine Analoge
HUP0203767A2 (hu) Új indolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
HUP0204084A2 (hu) Új heteroarilszármazékok, eljárás előállításukra és alkalmazásuk
ATE244010T1 (de) Arzneistoffkombination zur behandlung von kopfschmerzen mit mirtazapine und paracetamol oder nicht-steroiden entzündungshemmenden mitteln
ATE327749T1 (de) Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie
AR026756A1 (es) Nuevas combinaciones terapeuticas (s)-2-bencilamino-metil)-2,3,8,9-tetrahidro-7h-1,4-dioxino[2,3-e]indol-8-ona y neuroleticos para el tratamiento oprevencion de desordenes psicoticos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties